Greater DMARD use, improved clinical but not patient-reported outcomes in juvenile idiopathic arthritis: what are we missing?

Rheumatology (Oxford). 2024 Sep 1;63(SI2):SI110-SI111. doi: 10.1093/rheumatology/kead702.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adolescent
  • Antirheumatic Agents* / therapeutic use
  • Arthritis, Juvenile* / drug therapy
  • Child
  • Humans
  • Patient Reported Outcome Measures*
  • Treatment Outcome

Substances

  • Antirheumatic Agents